Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EARNING PER SHARE (Details)

v3.21.4
SCHEDULE OF EARNING PER SHARE (Details) - USD ($)
3 Months Ended 6 Months Ended
Nov. 30, 2021
Aug. 31, 2021
Nov. 30, 2020
Aug. 31, 2020
Nov. 30, 2021
Nov. 30, 2020
Accounting Policies [Abstract]            
Net income attributable to common stockholders $ 4,488,225 $ 2,023,416 $ 1,397,183 $ (574,137) $ 6,511,641 $ 823,046
Effect of dilutive securities: 391,035   175,356   776,515 175,356
Diluted net income $ 4,879,260   $ 1,572,539   $ 7,288,156 $ 998,402
Weighted average common shares outstanding – basic 1,764,049,961   1,393,560,488   1,687,489,133 1,308,705,539
Series A Preferred $ 1,316,157,000   $ 1,177,041,100   $ 1,316,157,000 $ 1,177,041,100
Series B Preferred 5,499,034,800   5,499,034,800   5,499,034,800 5,499,034,800
Convertible notes 2,320,223,646   1,236,932,052   2,320,223,646 1,236,932,052
Warrants    
Weighted average common shares outstanding and assumed conversion – diluted 10,899,465,407   9,306,568,440   10,822,904,579 9,221,713,491
Basic net income per common share $ 0.00   $ 0.00   $ 0.00 $ 0.00
Diluted net income per common share $ 0.00   $ 0.00   $ 0.00 $ 0.00
(a) - Anti-dilutive securities excluded: